The Role of Electrophysiological Study in the Risk Stratification of Brugada Syndrome.
Journal
Cardiology in review
ISSN: 1538-4683
Titre abrégé: Cardiol Rev
Pays: United States
ID NLM: 9304686
Informations de publication
Date de publication:
02 May 2023
02 May 2023
Historique:
medline:
1
5
2023
pubmed:
1
5
2023
entrez:
1
5
2023
Statut:
aheadofprint
Résumé
Brugada syndrome (BrS) is a complex arrhythmogenic disease associated with an increased risk of sudden cardiac death (SCD). The role of electrophysiological study (EPS) for risk stratification purposes of asymptomatic BrS patients remains still controversial. This study aims to summarize the existing data about the role of electrophysiological study for arrhythmic risk stratification of BrS patients without a prior history of aborted SCD or fatal arrhythmic event. Two independent investigators (G.B. and G.T.) performed a systematic search in the MedLine database and Cochrane library from their inception until April 2022 without any limitations. The reference lists of the relevant research studies as well as the relevant review studies and meta-analyses were manually searched. Nineteen studies were included in the final analysis. The included studies enrolled 6218 BrS patients (mean age: 46.9 years old, males: 76%) while 4265 (68.6%) patients underwent an EPS. The quantitative synthesis showed that a positive EPS study was significantly associated with arrhythmic events in BrS patients (RR, 1.74 [1.23-2.45]; P = 0.002; I2 = 63%]. By including the studies that provided data on the association of EPS with arrhythmic events during follow-up in patients without a prior history of aborted SCD or fatal arrhythmic event, the association between positive EPS study and future arrhythmic events remained significant (RR, 1.60 [1.08-2.36]; P = 0.02; I2 = 19%). In conclusion, EPS is a useful invasive tool for the risk stratification of BrS patients and can be used to identify the population of BrS patients who may be candidates for primary prevention of SCD with implantable cardioverter-defibrillator (ICD) implantation.
Identifiants
pubmed: 37126436
doi: 10.1097/CRD.0000000000000561
pii: 00045415-990000000-00106
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to report.
Références
Behr ER, Ben-Haim Y, Ackerman MJ, et al. Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway? Eur Heart J. 2021;42:1073–1081.
Letsas KP, Asvestas D, Baranchuk A, et al. Prognosis, risk stratification, and management of asymptomatic individuals with Brugada syndrome: a systematic review. Pacing Clin Electrophysiol. 2017;40:1332–1345.
Letsas KP, Bazoukis G, Efremidis M, et al. Clinical characteristics and long-term clinical course of patients with Brugada syndrome without previous cardiac arrest: a multiparametric risk stratification approach. Europace. 2019;21:1911–1918.
Babai Bigi MA, Aslani A, Shahrzad S. aVR sign as a risk factor for life-threatening arrhythmic events in patients with Brugada syndrome. Heart Rhythm. 2007;4:1009–1012.
Calo L, Giustetto C, Martino A, et al. A new electrocardiographic marker of sudden death in Brugada syndrome: the S-Wave in lead I. J Am Coll Cardiol. 2016;67:1427–1440.
Lee S, Zhou J, Chung CT, et al. Comparing the performance of published risk scores in Brugada syndrome: a multi-center cohort study. Curr Probl Cardiol. 2022;47:101381.
Moher D, Liberati A, Tetzlaff J, et al.; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Marshall SC, Molnar F, Man-Son-Hing M, et al. Predictors of driving ability following stroke: a systematic review. Top Stroke Rehabil. 2007;14:98–114.
Takagi M, Sekiguchi Y, Yokoyama Y, et al.; Japan Idiopathic Ventricular Fibrillation Study (J-IVFS) Investigators. The prognostic impact of single extra-stimulus on programmed ventricular stimulation in Brugada patients without previous cardiac arrest: multi-centre study in Japan. Europace. 2018;20:1194–1200.
Sieira J, Conte G, Ciconte G, et al. Prognostic value of programmed electrical stimulation in Brugada syndrome: 20 years experience. Circ Arrhythm Electrophysiol. 2015;8:777–784.
Priori SG, Gasparini M, Napolitano C, et al. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol. 2012;59:37–45.
Rodriguez-Manero M, Baluja A, Hernandez J, et al. Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study. Rev Esp Cardiol (Engl Ed). 2022;75:559–567.
Tse G, Wong ST, Tse V, et al. Depolarization vs. repolarization: what is the mechanism of ventricular arrhythmogenesis underlying sodium channel haploinsufficiency in mouse hearts?. Acta Physiol. 2016;218:234–235.
Biasi N, Seghetti P, Tognetti A. Diffuse fibrosis and repolarization disorders explain ventricular arrhythmias in Brugada syndrome: a computational study. Sci Rep. 2022;12:8530.
Handa BS, Li X, Baxan N, et al. Ventricular fibrillation mechanism and global fibrillatory organization are determined by gap junction coupling and fibrosis pattern. Cardiovasc Res. 2021;117:1078–1090.
Fauchier L, Isorni MA, Clementy N, et al. Prognostic value of programmed ventricular stimulation in Brugada syndrome according to clinical presentation: an updated meta-analysis of worldwide published data. Int J Cardiol. 2013;168:3027–3029.
Paul M, Gerss J, Schulze-Bahr E, et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J. 2007;28:2126–2133.